John Cho Selected Research

John Cho Research Topics

Disease

20	Neoplasms (Cancer) 01/2023 - 11/2008
10	Carcinoma (Carcinomatosis) 10/2022 - 03/2016
7	Squamous Cell Carcinoma of Head and Neck 01/2020 - 10/2016
7	Malignant Mesothelioma 11/2019 - 01/2014
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 11/2008
5	Neoplasm Metastasis (Metastasis) 01/2019 - 03/2016
4	Nasopharyngeal Carcinoma 07/2023 - 01/2016
4	Oropharyngeal Neoplasms 01/2021 - 11/2016
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2021 - 12/2010
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 11/2016
3	Mesothelioma 01/2017 - 01/2014
2	Osteoradionecrosis 10/2023 - 10/2017
2	Fibrosis (Cirrhosis) 11/2022 - 08/2014
2	Fatigue 07/2020 - 10/2018
2	Margins of Excision 01/2017 - 12/2013
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 11/2020
1	COVID-19 01/2020
1	Disease Progression 01/2019
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2019
1	Hypothyroidism 10/2018
1	Chronic Disease (Chronic Diseases) 10/2018
1	Extranodal Extension 01/2017
1	Tonsillar Neoplasms 01/2017
1	Hypopharyngeal Neoplasms 11/2016
1	Exanthema (Rash) 10/2016
1	Hypertension (High Blood Pressure) 10/2016
1	Diarrhea 10/2016
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2016
1	Paraganglioma (Paragangliomas) 01/2016
1	Pheochromocytoma 01/2016
1	Hypertensive Crisis 01/2016
1	Abdominal Pain (Pain, Abdominal) 01/2016
1	Hyperphagia (Overeating) 06/2015
1	Body Weight (Weight, Body) 06/2015
1	Obesity 06/2015
1	Cicatrix (Scar) 08/2014
1	Weight Loss (Weight Reduction) 04/2011
1	Lymphoma (Lymphomas) 09/2003
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2003

Drug/Important Bio-Agent (IBA)

6	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 04/2011
2	AsbestosIBA 11/2019 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 11/2018 - 01/2016
2	ErbB Receptors (EGF Receptor)IBA 10/2016 - 01/2012
2	Pemetrexed (MTA)FDA Link 03/2016 - 04/2011
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 07/2020
1	Messenger RNA (mRNA)IBA 11/2019
1	Hormones (Hormone)IBA 10/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2018
1	dacomitinibIBA 10/2016
1	Cetuximab (Erbitux)FDA Link 10/2016
1	PlatinumIBA 03/2016
1	CatecholaminesIBA 01/2016
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2016
1	LeptinIBA 06/2015
1	Carbon DioxideIBA 06/2015
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 06/2015
1	OligonucleotidesIBA 06/2015
1	NeuropeptidesIBA 06/2015
1	Tyrosine Kinase InhibitorsIBA 01/2012
1	XL647IBA 01/2012
1	Phosphotransferases (Kinase)IBA 01/2012
1	Gefitinib (Iressa)FDA Link 01/2012
1	tyrosine receptor (receptor, tyrosine)IBA 01/2012
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2012

Therapy/Procedure

33	Radiotherapy 10/2023 - 11/2008
11	Therapeutics 01/2023 - 12/2013
8	Drug Therapy (Chemotherapy) 01/2022 - 09/2003
6	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022 - 01/2017
4	Pneumonectomy (Lung Volume Reduction) 01/2022 - 01/2014
4	Chemoradiotherapy 01/2020 - 11/2016
2	Cranial Irradiation 09/2021 - 12/2010
2	Image-Guided Radiotherapy 11/2018 - 12/2012
2	Aftercare (After-Treatment) 10/2017 - 11/2015
2	Induction Chemotherapy 09/2016 - 01/2014
1	Dental Care 10/2023
1	Adjuvant Chemotherapy 01/2020
1	Polypharmacy 01/2017
1	Neck Dissection (Radical Neck Dissection) 01/2017
1	Laryngectomy 01/2016
1	Re-Irradiation 01/2016